Paula G Fraenkel

4PUBLICATIONS
103CO-AUTHORS
NanomedicineMolecular targetsAircraft performance and flight control systemsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 18, 2026
Safety and efficacy of intratumoral MEDI1191, an IL-12 mRNA lipid nanoparticle, plus intravenous durvalumab in patients with advanced solid tumors: a first-in-human study.

|Jul 13, 2026
Osimertinib Plus Gefitinib in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer and EGFR (C797X) Mutation Following First-Line Osimertinib: ORCHARD.

|Oct 15, 2025
Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing Cancers.

Jason J Zoeller, Ravinder Tammali, Roger B Dodd

|Sep 03, 2025
IPH5201, an Anti-CD39 mAb, as Monotherapy or in Combination with Durvalumab in Advanced Solid Tumors.

John Powderly, Martina Imbimbo, Antoine Italiano

Pageof 1

Frequent Collaborators

2 joint publications

Eduardo Castanon Alvarez

2 joint publications

Benedito A Carneiro

1 joint publications

John Powderly

1 joint publications

Martina Imbimbo